These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 1972861)

  • 1. Neuroendocrine changes post myocardial infarction: effects of xamoterol.
    McMurray JJ; Lang CC; MacLean D; McDevitt DG; Struthers AD
    Am Heart J; 1990 Jul; 120(1):56-62. PubMed ID: 1972861
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of xamoterol in acute myocardial infarction: blood pressure, heart rate, arrhythmias and early clinical course.
    McMurray J; Lang CC; MacLean D; Struthers AD; McDevitt DG
    Int J Cardiol; 1991 Jun; 31(3):295-303. PubMed ID: 1679047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lack of tolerance development after long-term administration of the partial beta-adrenoceptor agonist xamoterol.
    Erlemeier HH; Kupper W; Bleifeld W
    Cardiology; 1990; 77(1):30-9. PubMed ID: 1972349
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improvement of left ventricular contractility and relaxation with the beta 1-adrenergic receptor partial agonist xamoterol at rest and during exercise in patients with postinfarction left ventricular dysfunction. A placebo-controlled randomized trial.
    de Feyter PJ; Serruys PW; Suryapranata H
    Circulation; 1990 Feb; 81(2 Suppl):III99-106. PubMed ID: 1967562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sympathetic modulation in practice: the German clinical experience.
    Kupper W; Erlemeier HH; Bleifeld W
    Eur Heart J; 1990 Apr; 11 Suppl A():19-25. PubMed ID: 1971586
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurohormonal activation in heart failure after acute myocardial infarction treated with beta-receptor antagonists.
    Persson H; Andréasson K; Kahan T; Eriksson SV; Tidgren B; Hjemdahl P; Hall C; Erhardt L
    Eur J Heart Fail; 2002 Jan; 4(1):73-82. PubMed ID: 11812667
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of xamoterol, a beta 1 adrenoceptor partial agonist, in patients with ischaemic dysfunction of the left ventricle.
    Vigholt-Sørensen E; Faergeman O; Snow HM
    Br Heart J; 1989 Nov; 62(5):335-41. PubMed ID: 2574049
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term effects of xamoterol on left ventricular diastolic function and late remodeling: a study in patients with anterior myocardial infarction and single-vessel disease.
    Pouleur H; van Eyll C; Hanet C; Cheron P; Charlier AA; Rousseau MF
    Circulation; 1988 May; 77(5):1081-9. PubMed ID: 2896076
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of xamoterol on resting and exercise haemodynamics in patients with chronic heart failure.
    Virk SJ; Davies MK
    Br J Clin Pharmacol; 1989; 28 Suppl 1(Suppl 1):15S-22S. PubMed ID: 2572250
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beta, partial agonists to treat heart failure: effects of xamoterol upon cardiac function and clinical status.
    Heng MK
    Clin Cardiol; 1990 Mar; 13(3):171-6. PubMed ID: 1969783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of the partial beta 1-agonist xamoterol on heart rate and ventricular arrhythmias in patients with mild to moderate heart failure.
    Virk SJ; Anfilogoff NH; Lawson N; Qiang F; Murray RG; Littler WA; Davies MK
    Eur Heart J; 1990 Oct; 11(10):876-84. PubMed ID: 1979946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of xamoterol in failing human myocardium.
    Schwinger RH; Böhm M; Erdmann E
    Eur Heart J; 1990 Apr; 11(4):323-7. PubMed ID: 1970536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The pharmacology of xamoterol: a basis for modulation of the autonomic control of the heart.
    Snow HM
    Br J Clin Pharmacol; 1989; 28 Suppl 1(Suppl 1):3S-13S. PubMed ID: 2572252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hemodynamic and humoral changes following intravenous administration of xamoterol in patients with heart failure and coronary heart disease].
    Erlemeier HH; Kupper W; Bleifeld W
    Z Kardiol; 1990 Feb; 79(2):126-33. PubMed ID: 1969685
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective beta-adrenoceptor partial agonist effects of pindolol and xamoterol on skeletal muscle assessed by plasma creatine kinase changes in healthy subjects.
    Tomlinson B; Cruickshank JM; Hayes Y; Renondin JC; Lui JB; Graham BR; Jones A; Lewis AD; Prichard BN
    Br J Clin Pharmacol; 1990 Nov; 30(5):665-72. PubMed ID: 1980200
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improvement of global and regional left ventricular function in patients with previous myocardial infarction by a new beta 1 adrenoceptor partial agonist, ICI 118,587.
    Pouleur H; Rousseau MF; Mengeot P; Veriter C; Vincent MF; Brasseur LA
    Eur Heart J; 1982 Dec; 3 Suppl D():123-7. PubMed ID: 6130945
    [No Abstract]   [Full Text] [Related]  

  • 17. [Role of adrenergic beta receptor partial agonists in left ventricular failure of ischemic origin. Value of xamoterol (ICI 118,587, Corwin)].
    Rousseau MF; Cheron P; Nannan M; Vincent MF; Lavenne F; Pouleur H
    Ann Med Interne (Paris); 1985; 136(3):247-50. PubMed ID: 2862823
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exercise capacity, arrhythmias, humoral and chemical parameters during long-term therapy with xamoterol.
    Erlemeier HH; Kupper W; Bleifeld W
    Int J Cardiol; 1990 Aug; 28(2):197-208. PubMed ID: 1697569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of the autonomic control of the failing heart.
    Snow HM
    Basic Res Cardiol; 1989; 84 Suppl 1():163-76. PubMed ID: 2573339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Long-term effect of xamoterol "Corwin", beta 1 partial agonist, on hemodynamics and treadmill exercise in patients with previous myocardial infarction].
    Shimizu M; Tsuyusaki T; Kawaguchi T; Kitazumi H; Yoshizawa Y; Kuramochi K; Kawano M; Kodama T; Kawano T; Ogata N
    Kokyu To Junkan; 1988 Dec; 36(12):1339-46. PubMed ID: 2907943
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.